Last reviewed · How we verify
NCT05827419
Hearing and Balance Disorders in Peripheral Neuropathy
trial in Charcot-Marie-Tooth Disease in 1 participant. Terminated before completion.
10 March 2023
Quick facts
| Lead sponsor | Nemours Children's Clinic |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 1 June 2018 |
| Primary completion | 10 March 2023 |
| Estimated completion | 10 March 2023 |
| Sites | 1 location across United States |
Conditions studied
- Charcot-Marie-Tooth Disease — all drugs for Charcot-Marie-Tooth Disease →
Sponsor
Nemours Children's Clinic
Who can join
Adults 5 to 21, any sex, with Charcot-Marie-Tooth Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The long term goal of this proposal is to precisely characterize the auditory and vestibular abilities of children with Charcot-Marie-Tooth (CMT) and how these abilities evolve during the progression of the disorder. This information will be used to refine the management methods for hearing loss and vestibular disorders in these patients. Given that the phenotypic severity is variable within the CMT patient population, we predict that not all CMT patients will present with auditory and vestibular dysfunction. We will therefore collect specimens (i.e., buccal swabs and saliva) from study participants so that their DNA can be isolated and used to determine the genetic basis for auditory and vestibular dysfunction in peripheral neuropathies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05827419
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Charcot-Marie-Tooth Disease
Currently open trials in the same condition.
- NCT06203093 — Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking · recruiting
- NCT04762758 — Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients · Phase 3 · active not recruiting
- NCT04010188 — A Registered Cohort Study on Charcot-Marie-Tooth Disease · recruiting
- NCT05902351 — Natural History Study for Charcot Marie Tooth Disease · recruiting
Other Nemours Children's Clinic trials
Trials by the same sponsor.
- NCT06616818 — DASH Diet Intervention for Systemic Hypertension in Adolescents · NA · withdrawn
- NCT07218588 — Sanctuary Farm Prescription in Adolescents · NA · recruiting
- NCT06406621 — Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker · NA · recruiting
- NCT07154667 — Evaluation of the Auryzon™ EAR 2.0 System in Ear Reconstruction · NA · recruiting
- NCT07212049 — Ultrasound Use to Measure Magnetically Controlled Growing Rods · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05827419 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nemours Children's Clinic
- Last refreshed: 25 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05827419.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing